Invited Presentations

  • The Epidemiology of DVT - WHO Report, Geneva (1991) Cohen AT and Kakkar VV.
  • "Risk factors for bleeding in surgery" at Thromboprophylaxis in Surgery, TRI, London 1992.
  • "Thrombin inhibitor and coronary angioplasty - Results of an international trial" at XIV Congress of the International Society for Thrombosis and Haemostasis, New York, 1993.
  • "The changing pattern of venous thromboembolic disease." International Society Thrombosis. Bilbao, Spain, June 1994.
  • "Risk factors for perioperative bleeding in patients receiving heparin prophylaxis." Surgical Research Society. Glasgow, July 1994.
  • "Low molecular weight heparin in vascular surgery". Thrombosis Update Symposium. Oslo March 1995.
  • "Fragmin in the prevention of recurrent thrombosis”. Thrombosis Update Symposium. Oslo March 1995.
  • "Ultra Low Molecular Weight Heparins”. International Union of Angiology. Sydney, December 1995.
  • "Use of Low Molecular Weight Heparins in Cardiovascular Disease”. International Union of Angiology. Sydney, December 1995.
  • "Essential Statistics - with examples”. The Institute of Orthopaedics, University College London. London, March 1996.
  • "Heparin induced Osteoporosis”. The King's Bone Group, KCSMD, University London. London, May 1996.
  • "Low molecular weight heparin for the treatment of venous thromboembolism". Best Clinical Practice Meeting, KCSMD, University London. London, July 1996.
  • "A review of 6,748 venograms". ANZ Angiology Meeting, Adelaide, October 1996.
  • "Severity of DVT and development of Post-phlebitic syndrome”. ANZ Angiology Meeting, Adelaide, October 1996.
  • "HRT and venous thromboembolism - epidemiology and basic concepts” RPMS Institute of Obstetrics and Gynaecology, University of London, March 1997.
  • "Perioperative adverse cardiac outcomes - epidemiology and therapeutic approaches”. European Society of Anaesthesiology, Lausanne, Switzerland, May 1997.
  • "Blood coagulation and the sex hormones - What to tell the patient?”. British Menopause Society Annual Meeting, Birmingham University, UK, June 1997.
  • "Risk assessment models in thromboprophylaxis for orthopaedic surgery”. Thrombosis Forum. Barcelona, Spain, 26 June 1998.
  • "Management of the non-surgical moderate- and high-risk patient”. The International Society of Haematology - European Haematology Association Combined Congress. Amsterdam, The Netherlands. 4 July 1998.
  • "Risk assessment models in thromboprophylaxis for orthopaedic surgery”. XIII World Congress of the International Union of Phlebology. Sydney, Australia. 8 September 1998.
  • 5.6.21"Prophylaxis in medical patients”. XIII World Congress of the International Union of Phlebology. Sydney, Australia. 8 September 1998.
  • "Efficacy and bleeding risk of low molecular weight heparin in the prophylaxis of deep vein thrombosis after orthopaedic/trauma surgery”. 11th Reunion Nationale, Groupe d’Etude Thrombose et Hemostase en Chirurgie de l’Appareil Loco-motor (GETHCAM), Lyon, France, 9th October 1998.
  • “The Management of Venous Thromboembolism” SE Thames SpR      training, KCH. 9 December 1998.
  • “DVT prophylaxis with LMWH in hospital patients”. Spanish National Congress of Vascular Surgery, Almeria, Spain. 4 June 1999.